EUR 3.47
(0.14%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 112.68 Million EUR | -8.68% |
2022 | 123.39 Million EUR | 18.99% |
2021 | 103.69 Million EUR | 13.61% |
2020 | 91.27 Million EUR | 14.06% |
2019 | 80.01 Million EUR | -33.68% |
2018 | 120.65 Million EUR | 10.22% |
2017 | 109.46 Million EUR | 136.25% |
2016 | 46.33 Million EUR | 27.5% |
2015 | 36.34 Million EUR | -5.87% |
2014 | 38.6 Million EUR | -55.8% |
2013 | 87.34 Million EUR | -14.39% |
2012 | 102.02 Million EUR | -17.39% |
2011 | 123.5 Million EUR | -6.14% |
2010 | 131.58 Million EUR | 16.41% |
2009 | 113.03 Million EUR | -4.45% |
2008 | 118.3 Million EUR | -2.53% |
2007 | 121.37 Million EUR | 31.1% |
2006 | 92.58 Million EUR | 9.67% |
2005 | 84.41 Million EUR | 22.55% |
2004 | 68.88 Million EUR | -14.05% |
2003 | 80.14 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | - EUR | -100.0% |
2024 Q2 | 151.52 Million EUR | 0.0% |
2023 FY | 112.68 Million EUR | -8.68% |
2023 Q2 | 110.66 Million EUR | 0.0% |
2023 Q1 | - EUR | -100.0% |
2023 Q3 | - EUR | -100.0% |
2023 Q4 | 112.43 Million EUR | 0.0% |
2022 FY | 123.39 Million EUR | 18.99% |
2022 Q2 | 96.31 Million EUR | 0.0% |
2022 Q4 | 123.39 Million EUR | 0.0% |
2022 Q1 | - EUR | -100.0% |
2022 Q3 | - EUR | -100.0% |
2021 Q3 | - EUR | -100.0% |
2021 FY | 103.69 Million EUR | 13.61% |
2021 Q4 | 103.69 Million EUR | 0.0% |
2021 Q1 | - EUR | -100.0% |
2021 Q2 | 78.69 Million EUR | 0.0% |
2020 FY | 91.27 Million EUR | 14.06% |
2020 Q4 | 91.27 Million EUR | 0.0% |
2020 Q1 | - EUR | -100.0% |
2020 Q2 | 89.5 Million EUR | 0.0% |
2019 FY | 80.01 Million EUR | -33.68% |
2019 Q1 | - EUR | -100.0% |
2019 Q2 | 91.44 Million EUR | 0.0% |
2019 Q3 | 80.01 Million EUR | -12.5% |
2019 Q4 | 80.01 Million EUR | 0.0% |
2018 Q2 | 122.44 Million EUR | 0.0% |
2018 Q1 | - EUR | -100.0% |
2018 FY | 120.65 Million EUR | 10.22% |
2018 Q4 | 120.65 Million EUR | 0.0% |
2018 Q3 | - EUR | -100.0% |
2017 FY | 109.46 Million EUR | 136.25% |
2017 Q3 | - EUR | -100.0% |
2017 Q4 | 109.46 Million EUR | 0.0% |
2017 Q2 | 118.08 Million EUR | 0.0% |
2017 Q1 | - EUR | -100.0% |
2016 Q1 | - EUR | -100.0% |
2016 Q2 | 44.34 Million EUR | 0.0% |
2016 Q3 | - EUR | -100.0% |
2016 Q4 | 46.33 Million EUR | 0.0% |
2016 FY | 46.33 Million EUR | 27.5% |
2015 Q3 | - EUR | -100.0% |
2015 FY | 36.34 Million EUR | -5.87% |
2015 Q4 | 36.34 Million EUR | 0.0% |
2015 Q2 | 42.48 Million EUR | 0.0% |
2015 Q1 | - EUR | -100.0% |
2014 Q4 | 38.6 Million EUR | 0.0% |
2014 FY | 38.6 Million EUR | -55.8% |
2014 Q1 | - EUR | -100.0% |
2014 Q2 | 78.97 Million EUR | 0.0% |
2014 Q3 | - EUR | -100.0% |
2013 FY | 87.34 Million EUR | -14.39% |
2013 Q2 | 102.41 Million EUR | 0.0% |
2013 Q4 | 87.34 Million EUR | 0.0% |
2013 Q3 | - EUR | -100.0% |
2013 Q1 | - EUR | -100.0% |
2012 Q3 | - EUR | -100.0% |
2012 Q2 | 124.15 Million EUR | 0.0% |
2012 FY | 102.02 Million EUR | -17.39% |
2012 Q4 | 102.02 Million EUR | 0.0% |
2011 FY | 123.5 Million EUR | -6.14% |
2011 Q2 | 133.73 Million EUR | 0.0% |
2011 Q4 | 123.5 Million EUR | 0.0% |
2010 FY | 131.58 Million EUR | 16.41% |
2009 FY | 113.03 Million EUR | -4.45% |
2008 FY | 118.3 Million EUR | -2.53% |
2007 FY | 121.37 Million EUR | 31.1% |
2006 FY | 92.58 Million EUR | 9.67% |
2005 FY | 84.41 Million EUR | 22.55% |
2004 FY | 68.88 Million EUR | -14.05% |
2003 FY | 80.14 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Almirall, S.A. | 911.58 Million EUR | 87.639% |
Laboratorio Reig Jofre, S.A. | 124.61 Million EUR | 9.58% |